Title: Histopathological Results in Patients With Prostate Specific Antigen Below 1.5 ng / ml
Abstract: Objectives: Prostate specific antigen (PSA) is the most commonly used marker for prostate cancer. PSA-based screening has reduced disease-specific mortality. However, PSA is not specific for prostate cancer, but is specific for prostate tissue and increases in benign conditions. Material and Methods: In our study, 63 patients with PSA values of 1.5 ng / ml or less were evaluated retrospectively with 636 patients who underwent prostate sampling because of the suspicion of prostate cancer. Results: In our study, 34.9% prostate cancer and 4.1% ASAP were detected below 1.5 ng / ml of PSA. Our results suggest that a significant number of cancers were detected below 1.5 ng / ml of PSA. Conclusion: A significant number of prostate cancers are found below 1.5 ng / ml PSA. The lack of a PSA value that we can say without prostate cancer leads to the need for a low cost and reliable marker.
Publication Year: 2017
Publication Date: 2017-11-24
Language: en
Type: article
Indexed In: ['crossref']
Access and Citation
AI Researcher Chatbot
Get quick answers to your questions about the article from our AI researcher chatbot